These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4932340)

  • 41. Experience with large-dose intravenous antithymocyte globulin in primates and man.
    Cosimi AB; Skamene E; Bonney WW; Russell PS
    Surgery; 1970 Jul; 68(1):54-61. PubMed ID: 4193070
    [No Abstract]   [Full Text] [Related]  

  • 42. Prolongation of survival of allogeneic skin grafts by L-asparaginase. Preliminary report.
    Hammer C; Brendel W
    Eur Surg Res; 1971; 3(1):72-5. PubMed ID: 4939504
    [No Abstract]   [Full Text] [Related]  

  • 43. Beneficial effects of heterologous antilymphoid globulins in renal transplantation: one "believer's" view.
    Hardy MA
    Am J Kidney Dis; 1982 Jul; 2(1):79-86. PubMed ID: 7048905
    [No Abstract]   [Full Text] [Related]  

  • 44. Antilymphocyte serum and procarbazine compared as immunosuppressants in mice, rats and rabbits.
    Stewart PB; Bell R
    Laval Med; 1970 Apr; 41(4):599-606. PubMed ID: 4929813
    [No Abstract]   [Full Text] [Related]  

  • 45. Prevention of rejection of porcine renal allografts.
    Perper RJ; Bowersox BE; VanGorder TJ
    Transplant Proc; 1971 Mar; 3(1):488-93. PubMed ID: 4937923
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of rosette formation by spleen cells from grafted mice treated with anti-lymphocyte serum.
    Mosedale B; Parke JA
    Transplantation; 1970 Oct; 10(4):347-9. PubMed ID: 4927390
    [No Abstract]   [Full Text] [Related]  

  • 47. The current status of transplantation immunology.
    Lessof MH
    Sci Basis Med Annu Rev; 1972; ():16-32. PubMed ID: 4565772
    [No Abstract]   [Full Text] [Related]  

  • 48. Protective action of homologous serum component on graft rejection.
    Hasek M; Karakoz I; Skamene E; Chutna J; Nouza K; Bubenik J; Nemec M; Sovova V
    Transplant Proc; 1969 Mar; 1(1):527-9. PubMed ID: 4944266
    [No Abstract]   [Full Text] [Related]  

  • 49. Passenger cells in rat heart allografts. No effect of removal.
    Nielsen HE; Heron I; Koch C
    Transplantation; 1975 Apr; 19(4):360-3. PubMed ID: 1098240
    [No Abstract]   [Full Text] [Related]  

  • 50. [Orthotopic transplantation of the liver in dogs (50 cases). Trial use of antilymphocyte serum].
    Moreaux J; Huguet C; Hugier M; Martin E; Bloch P
    Nouv Presse Med; 1972 Jan; 1(5):338. PubMed ID: 4551595
    [No Abstract]   [Full Text] [Related]  

  • 51. Suppression of canine renal allograft rejection with antilymphocyte serum.
    Clunie GJ; Howard RR; Robinson E; Morton H
    Aust N Z J Surg; 1969 Aug; 39(1):68-71. PubMed ID: 4898557
    [No Abstract]   [Full Text] [Related]  

  • 52. [Importance of presensitization and the morphological characteristics of rejection in repeated kidney transplants].
    Belorusov OS; Morozova MM; Polishchuk RV; Boĭko OV
    Khirurgiia (Mosk); 1981 Jun; (6):64-8. PubMed ID: 7019548
    [No Abstract]   [Full Text] [Related]  

  • 53. Mechanism of permanent survival of canine renal allografts following a limited course of ALS treatment.
    Shanfield I; Wolf JS; Wren SF; MacLean LD; Hume DM
    Transplant Proc; 1973 Mar; 5(1):533-4. PubMed ID: 4572113
    [No Abstract]   [Full Text] [Related]  

  • 54. Long-term skin allograft survical elicited by a finite treatment with antilymphocyte serum combined with cytarabine.
    Perper RJ; Monovich RE; Bowersox BE
    J Immunol; 1970 May; 104(5):1063-71. PubMed ID: 4910473
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunosuppressive effects of heterologous antilymphocyte serum in monkeys.
    Lance EM; Medawar PB
    Lancet; 1970 Jan; 1(7639):167-70. PubMed ID: 4189240
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunosuppressive properties of corticosteroids. I. Aldosterone as immunosuppressant in skin allograts in rats.
    Baethmann A; Land W; Koczorek KR; Stass P; Brendel W
    Eur Surg Res; 1971; 3(1):40-50. PubMed ID: 4939501
    [No Abstract]   [Full Text] [Related]  

  • 57. [Importance of the immunological enhancement for the survival time of a homologous graft].
    Benkö A
    Z Gesamte Inn Med; 1971 Jun; 26(11):345-52. PubMed ID: 4397958
    [No Abstract]   [Full Text] [Related]  

  • 58. Mechanism of augmented graft survival in mice after ALS and bone marrow infusion.
    Wood ML; Heppner G; Gozzo JJ; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):691-6. PubMed ID: 4572128
    [No Abstract]   [Full Text] [Related]  

  • 59. Controlled clinical trial of antilymphocyte globulin in human renal allografts.
    Birtch AG; Carpenter CB; Tilney NL; Hampers CL; Hager FB; Levine L; Wilson RE; Murray JE
    Transplant Proc; 1971 Mar; 3(1):762-5. PubMed ID: 4937969
    [No Abstract]   [Full Text] [Related]  

  • 60. Pathology of rejection of heart and skin xenografts.
    Dodd DC; Donawick WJ
    Vet Pathol; 1973; 10(6):520-9. PubMed ID: 4608766
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.